BrightSpring Health Services, Inc. $BTSG Shares Sold by AXQ Capital LP

AXQ Capital LP lessened its stake in BrightSpring Health Services, Inc. (NASDAQ:BTSG) by 67.7% in the third quarter, Holdings Channel reports. The fund owned 6,823 shares of the company’s stock after selling 14,316 shares during the quarter. AXQ Capital LP’s holdings in BrightSpring Health Services were worth $202,000 as of its most recent SEC filing.

A number of other hedge funds also recently made changes to their positions in the company. Lisanti Capital Growth LLC acquired a new position in shares of BrightSpring Health Services during the third quarter worth $1,959,000. Federated Hermes Inc. grew its holdings in BrightSpring Health Services by 44.8% during the 3rd quarter. Federated Hermes Inc. now owns 319,200 shares of the company’s stock valued at $9,436,000 after purchasing an additional 98,745 shares in the last quarter. Prescott Group Capital Management L.L.C. purchased a new stake in BrightSpring Health Services during the 3rd quarter worth $887,000. Ellsworth Advisors LLC acquired a new position in BrightSpring Health Services in the 3rd quarter worth $983,000. Finally, Bailard Inc. acquired a new position in BrightSpring Health Services in the 3rd quarter worth $378,000.

Key Headlines Impacting BrightSpring Health Services

Here are the key news stories impacting BrightSpring Health Services this week:

• Positive Sentiment: Q4 revenue topped expectations: BrightSpring reported $3.55B in Q4 sales versus ~ $3.38B consensus and revenue was up ~29.3% YoY—this top-line beat is the primary driver of the stock’s uptick. BrightSpring Health Services (NASDAQ:BTSG) Posts Better-Than-Expected Sales In Q4 CY2025
• Positive Sentiment: Management gave FY2026 revenue guidance roughly in line with or slightly above Street expectations (about $14.5B–$15.0B vs. $14.6B consensus), which supports continued revenue-driven growth expectations. BrightSpring Health Services, Inc. Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Full Year 2026 Guidance
• Neutral Sentiment: Management commentary and detail from the earnings call are available for investors evaluating margin drivers, mix and outlook; read the transcript for color on margin timing and growth drivers. BrightSpring (BTSG) Earnings Call Transcript
• Neutral Sentiment: Some company-provided guidance items were unclear in early release notes (EPS guidance not clearly stated in initial summaries); investors may await a management follow-up or the slide deck for clarification before fully re-pricing valuation.
• Neutral Sentiment: Reported short-interest figures for February appear to be erroneous (showing zero shares); treat those data points with caution as they won’t reliably explain share moves.
• Negative Sentiment: Q4 EPS missed consensus by $0.01 ($0.33 reported vs. $0.34 expected) and net margin remains slim (~1.0%), which keeps focus on profitability and justifies some valuation skepticism despite revenue growth. BrightSpring Health Services, Inc. (BTSG) Q4 Earnings Lag Estimates

BrightSpring Health Services Trading Up 3.2%

Shares of NASDAQ BTSG opened at $41.43 on Friday. The company has a quick ratio of 1.38, a current ratio of 1.79 and a debt-to-equity ratio of 1.36. The stock’s 50 day moving average price is $39.13 and its two-hundred day moving average price is $33.25. BrightSpring Health Services, Inc. has a 52-week low of $15.48 and a 52-week high of $44.87. The stock has a market capitalization of $7.47 billion, a P/E ratio of 67.92, a PEG ratio of 0.55 and a beta of 2.36.

BrightSpring Health Services (NASDAQ:BTSG) last issued its earnings results on Friday, February 27th. The company reported $0.33 EPS for the quarter, missing the consensus estimate of $0.34 by ($0.01). BrightSpring Health Services had a return on equity of 11.61% and a net margin of 1.04%.The firm had revenue of $3.55 billion during the quarter, compared to analyst estimates of $3.38 billion. BrightSpring Health Services’s revenue was up 29.3% compared to the same quarter last year. During the same quarter in the previous year, the business posted $0.11 EPS. On average, analysts anticipate that BrightSpring Health Services, Inc. will post 0.59 earnings per share for the current fiscal year.

Analyst Upgrades and Downgrades

Several brokerages have recently weighed in on BTSG. Stephens assumed coverage on BrightSpring Health Services in a research note on Wednesday, December 10th. They set an “overweight” rating and a $44.00 target price for the company. Wall Street Zen lowered BrightSpring Health Services from a “strong-buy” rating to a “buy” rating in a research note on Saturday, November 15th. William Blair initiated coverage on BrightSpring Health Services in a report on Monday, December 8th. They set an “outperform” rating on the stock. KeyCorp upgraded BrightSpring Health Services from a “sector weight” rating to an “overweight” rating and set a $45.00 target price for the company in a research note on Friday, December 12th. Finally, Wells Fargo & Company raised their price target on shares of BrightSpring Health Services from $39.00 to $43.00 and gave the stock an “overweight” rating in a research report on Wednesday, January 7th. One research analyst has rated the stock with a Strong Buy rating, thirteen have assigned a Buy rating and two have assigned a Hold rating to the stock. Based on data from MarketBeat, the company has a consensus rating of “Moderate Buy” and a consensus target price of $41.33.

BrightSpring Health Services Company Profile

BrightSpring Health Services (NASDAQ: BTSG) is a leading provider of home and community-based care and workforce solutions aimed at seniors, individuals with disabilities and those facing behavioral health challenges. The company’s operations encompass a broad spectrum of services, including personal care, skilled nursing, therapy, habilitation and supported living, as well as specialized behavioral health programs delivered through both clinical and non-clinical channels.

Through its network of subsidiary brands, BrightSpring offers integrated care in the patient’s home environment, fostering independence and improving quality of life.